These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16857799)

  • 1. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
    Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
    Houghton O; Connolly LE; McCluggage WG
    Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
    Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
    APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant intranuclear localization of biotin, biotin-binding enzymes, and beta-catenin in pregnancy-related endometrium and morule-associated neoplastic lesions.
    Gamachi A; Kashima K; Daa T; Nakatani Y; Tsujimoto M; Yokoyama S
    Mod Pathol; 2003 Nov; 16(11):1124-31. PubMed ID: 14614052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrioid Squamous Proliferations of the Endometrium Express Alpha-Methylacyl-CoA Racemase (P504s).
    Tahir M; Samankan S; Huang M; Pinto A
    Int J Gynecol Pathol; 2023 Nov; 42(6):576-581. PubMed ID: 37562065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of morules in colonic neoplasms: morules are morphologically and qualitatively different from squamous metaplasia.
    Ueo T; Kashima K; Daa T; Kondo Y; Sasaki A; Yokoyama S
    Pathobiology; 2005; 72(5):269-78. PubMed ID: 16374071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant beta-catenin expression.
    Nakatani Y; Masudo K; Nozawa A; Inayama Y; Yamanaka S; Ito T; Kitamura H; Notohara K; Kashima K; Yokoyama S; Tsujimoto M; Tamai S; Abe Y; Resl M; Mark EJ
    Hum Pathol; 2004 Jul; 35(7):869-74. PubMed ID: 15257551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma.
    McCluggage WG; Van de Vijver K
    Int J Gynecol Pathol; 2019 Sep; 38(5):397-403. PubMed ID: 30085940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
    Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation.
    Nicolae A; Preda O; Nogales FF
    J Clin Pathol; 2011 Feb; 64(2):97-106. PubMed ID: 21126963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
    Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
    Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
    Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A
    Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma.
    Travaglino A; Raffone A; Gencarelli A; Raimondo D; Moretta P; Pignatiello S; Granata M; Seracchioli R; Zullo F; Insabato L
    Pathol Res Pract; 2021 Jan; 217():153307. PubMed ID: 33316539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of squamous differentiation and morular metaplasia in uterine endometrioid adenocarcinoma.
    Blanco LZ; Heagley DE; Lee JC; Gown AM; Gattuso P; Rotmensch J; Guirguis A; Dewdney S; Bitterman P
    Int J Gynecol Pathol; 2013 May; 32(3):283-92. PubMed ID: 23518912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.